Vatican City— Catholic Church Called On To Counter Corporate Greed Fueling Harmful Psychiatric Drugging of Children

VATICAN CITY – The Catholic Church may be the only organization that can counter the corporate greed fueling the over-prescribing of harmful psychiatric drugs to children and young people, said Dr. Barry Duncan, a clinical psychologist and director of the Heart and Soul of Change Project. Flawed methodologies in research and a drastic minimization of actual risks make the cited efficiency and safety of these drugs untrustworthy, he told a meeting of the Pontifical Council for Health Care Ministry. And clinical trial evidence on psychiatric drugs is often skewed by conflicts of interests, particularly when trials are funded by the drug industry or when the studies are conducted by people who are paid consultants of the company under review, Duncan told the Nov. 18-19 meeting. He said because of the church’s broad networking capabilities and international influence, it “may be the only power on earth that can counter the forces of corporate greed that have no moral or ethical conscience.” He called on religious orders, Catholic schools, hospitals, medical associations, media and parishes to become informed and help children and families discover alternatives to psychiatric medications as well as help them have real input when discussing the risks and benefits of such medication.

He called on religious orders, Catholic schools, hospitals, medical associations, media and parishes to become informed and help children and families discover alternatives to psychiatric medications as well as help them have real input when discussing the risks and benefits of such medication.

Physicians on Pharma’s Payroll: Educators or Marketers?

For more than 20 years, psychiatrist Richard Schloss has been treating Long Island patients with schizophrenia, bipolar disorder and social phobias. But he has another job. Pfizer has paid him thousands of dollars to tell other psychiatrists about a drug the company sells, an anti-psychotic medication called Geodon.

In all his years of speaking for Pfizer, the company’s never asked Schloss (right) about an embarrassing stain on his state record. In 2001, the New York State Health Department suspended Schloss and then put him on probation for five years for helping supply Vicodin for a year and a half to six patients who were drug addicts.

Disciplined doctors receiving pharmaceutical funds

About 48 of the more than 1,730 California doctors who received money from pharmaceutical companies over the past 21 months have been the subject of disciplinary action, a database compiled by the investigative news organization ProPublica found. ProPublica found that the seven drug companies paid $6.7 million to 290 doctors who faced disciplinary action or other regulatory sanctions in various states. San Francisco psychiatrist Karin Hastik, for example, took $168,658 in speaking and consulting fees from Eli Lilly, AstraZeneca and GlaxoSmithKline since 2009. But in May, the Medical Board of California placed Hastik on probation for negligence, prescribing drugs without prior examination, and failing to keep adequate records about a patient she had been caring for since 2000. Hastik did not return calls for comment.

Justice to Pharma: “Do the Perp Walk!”

Former GSK counsel is the first target in government’s executive-liability crackdown. Could J&J be next? The US Department of Justice filed criminal charges last week against Lauren Stevens, a former VP and assistant general counsel at GlaxoSmithKline. Going after pharma execs marks a seismic shift in the government’s efforts to stem the tide of fraud and other illegal pharma marketing practices, which a raft of billion-dollar settlements have so far failed to end. Stevens is charged with obstruction of an investigation, concealment and falsification of documents, and making false statements to the FDA in its 2002 investigation of off-label promotion of the antidepressant Wellbutrin for weight loss, an indication for which it has never been approved but has shown some clinical benefit. The DoJ says that it has evidence, in the vast paper and electronic documentation turned over by GSK, showing that Stevens hid and otherwise misled the agency about some 1,000 instances of GSK-paid doctors promoting Wellbutrin for weight loss to other doctors.

Study Claims “ADHD Boys” Get in More Car Accidents—Fails to Mention ADHD Drug Side Effects & Recommends…More Drugging

It’s hard for anyone with a modicum of reason to understand how such glaringly flawed studies as the one posted below are pawned off on the public in the name of “mental health” recommendations. Case in point, a new “study” claims that “teenage boys with attention deficit hyperactivity disorder are twice as likely to be involved in a serious car collision.” Now, by the researchers own admission, “they couldn’t determine whether the teens with ADHD were taking medication when the crashes occurred.” Well that’s a seriously major omission. Any teenager who has been diagnosed “ADHD” is almost assuredly on drugs. The most common of which is methylphenidate (Ritalin, Adderall, Concerta, etc.) According to the U.S. FDA methylphenidate is documented to cause: Hallucinations, Delusional Thinking, Sensory Disturbances, Mania, Psychosis, Aggression, Violence, Headaches, Nausea, Vomiting, Depression, Sleepiness, Drowsiness, Fatigue, Agitation, Irritability, Insomnia, Disturbed Sleep, Abnormally Tight Muscles, Cardiac Events, Stroke and Cerebrovascular Events. All side effects that would seriously impair a person’s ability to drive.

SHARE YOUR STORY/COMMENT: